PL2999701T3 - 2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania - Google Patents

2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania

Info

Publication number
PL2999701T3
PL2999701T3 PL14724757T PL14724757T PL2999701T3 PL 2999701 T3 PL2999701 T3 PL 2999701T3 PL 14724757 T PL14724757 T PL 14724757T PL 14724757 T PL14724757 T PL 14724757T PL 2999701 T3 PL2999701 T3 PL 2999701T3
Authority
PL
Poland
Prior art keywords
phenylimidazo
pyrimidines
imaging agents
imaging
agents
Prior art date
Application number
PL14724757T
Other languages
English (en)
Inventor
Luca Gobbi
Henner Knust
Matthias Koerner
Dieter Muri
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL2999701T3 publication Critical patent/PL2999701T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL14724757T 2013-05-23 2014-05-19 2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania PL2999701T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13168830 2013-05-23

Publications (1)

Publication Number Publication Date
PL2999701T3 true PL2999701T3 (pl) 2017-09-29

Family

ID=48446195

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14724757T PL2999701T3 (pl) 2013-05-23 2014-05-19 2-fenyloimidazo[1,2-a]pirymidyny jako środki do obrazowania

Country Status (20)

Country Link
US (1) US9801961B2 (pl)
EP (1) EP2999701B1 (pl)
JP (1) JP6130055B2 (pl)
KR (1) KR101770494B1 (pl)
CN (1) CN105229009B (pl)
AR (1) AR096371A1 (pl)
AU (1) AU2014270524B2 (pl)
BR (1) BR112015025140A2 (pl)
CA (1) CA2907605A1 (pl)
DK (1) DK2999701T3 (pl)
ES (1) ES2629389T3 (pl)
HU (1) HUE033612T2 (pl)
MX (1) MX2015015893A (pl)
PL (1) PL2999701T3 (pl)
RU (1) RU2665580C2 (pl)
SG (1) SG11201509503QA (pl)
SI (1) SI2999701T1 (pl)
TW (1) TW201500360A (pl)
WO (1) WO2014187762A1 (pl)
ZA (1) ZA201506570B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107810188B (zh) 2015-04-08 2020-09-22 拜耳作物科学股份公司 作为害虫防治剂和中间体产物的稠合双环杂环衍生物
TW201718514A (zh) 2015-08-07 2017-06-01 拜耳作物科學股份有限公司 作為殺蟲劑之經2-(雜)芳基取代之稠合雜環衍生物
BR112018006005A2 (pt) 2015-09-29 2018-10-30 Oncotherapy Science Inc composto bicíclico e uso do mesmo para inibição de suv39h2
PE20181198A1 (es) 2015-10-26 2018-07-23 Bayer Cropscience Ag Derivados de heterociclos biciclicos condensados como agentes de control de plagas
WO2017093180A1 (de) 2015-12-01 2017-06-08 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CN105582168A (zh) * 2016-01-08 2016-05-18 王明强 一种治疗体弱多病、元气不足、免疫力低下的中药药剂
WO2017144341A1 (de) 2016-02-23 2017-08-31 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
WO2017174414A1 (de) 2016-04-05 2017-10-12 Bayer Cropscience Aktiengesellschaft Naphthalin-derivate als schädlingsbekämpfungsmittel
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
RU2019104378A (ru) 2016-07-19 2020-08-19 Байер Кропсайенс Акциенгезельшафт Конденсированные бициклические гетероциклические производные в качестве средств для борьбы с вредителями
WO2018015546A1 (en) 2016-07-22 2018-01-25 Ac Immune S.A. Compounds for imaging tau protein aggregates
KR102472003B1 (ko) 2016-07-22 2022-11-29 에이씨 이뮨 에스에이 타우 단백질 응집체를 이미징하기 위한 화합물
MX2019001918A (es) 2016-08-15 2019-09-06 Bayer Cropscience Ag Derivados del heterociclo biciclico condensado como agentes de control de plagas.
WO2018050825A1 (de) 2016-09-19 2018-03-22 Bayer Cropscience Aktiengesellschaft Pyrazolo[1,5-a]pyridin- derivative und ihre verwendung als schädlingsbekämpfungsmittel
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz
AR113206A1 (es) 2017-01-10 2020-02-19 Bayer Cropscience Ag Derivados heterocíclicos como pesticidas
UY37556A (es) 2017-01-10 2018-07-31 Bayer Ag Derivados heterocíclicos como pesticidas
WO2018138050A1 (de) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
KR102537983B1 (ko) 2017-04-24 2023-05-31 바이엘 악티엔게젤샤프트 해충 방제제로서의 축합된 비시클릭 헤테로시클릭-화합물 유도체
JP6831802B2 (ja) * 2018-01-12 2021-02-17 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. 放射性核種標識化合物及びこれを含有するイメージング剤
EP3305786A3 (de) 2018-01-22 2018-07-25 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3743423A1 (en) 2018-01-24 2020-12-02 AC Immune SA Gamma-carboline compounds for the detection of tau aggregates
US20210041447A1 (en) 2018-01-24 2021-02-11 Ac Immune Sa Azacarboline compounds for the detection of tau aggregates
US11019821B2 (en) 2018-02-21 2021-06-01 Bayer Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
WO2019234243A1 (en) * 2018-06-08 2019-12-12 Ac Immune Sa Novel compounds for diagnosis
PY2011993A (es) 2019-02-26 2021-07-05 Bayer Ag Derivados heterocíclos bicíclicos condensados como plaguicida
PY2012000A (es) 2019-02-26 2023-07-25 Bayer Ag Derivados de heterociclos bicíclicos fusionados como pesticidas
CN114890955A (zh) * 2022-06-23 2022-08-12 江西瑞威尔生物科技有限公司 一种n取代吗啉类有机化合物的制备工艺
CA3261365A1 (en) * 2022-07-28 2024-02-01 Ac Immune Sa NEW COMPOUNDS
AR134414A1 (es) * 2023-11-21 2026-01-14 Novartis Ag Imidazoarenos sustituidos y métodos para su uso

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237470T3 (es) * 1999-11-10 2005-08-01 Ortho-Mcneil Pharmaceutical, Inc. 2-aril-3-(heteroaril)-imidazo(1,2-alfa)pirimidinas sustituidas; y composiciones farmaceuticas y procedimientos asociados.
EP1294723A1 (en) * 2000-05-24 2003-03-26 MERCK SHARP & DOHME LTD. 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
JP2008546804A (ja) 2005-06-24 2008-12-25 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 造影剤として用いるためのリガンドの放射性標識ペグ化
US20080219922A1 (en) 2005-09-12 2008-09-11 Goodman Mark M Alzheimer's Disease Imaging Agents
WO2007034282A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists
WO2007063946A1 (ja) * 2005-11-30 2007-06-07 Fujifilm Ri Pharma Co., Ltd. アミロイドの凝集及び/又は沈着に起因する疾患の診断薬及び治療薬
WO2008118122A2 (en) * 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
US8303935B2 (en) 2006-05-19 2012-11-06 Nihon Medi-Physics Co., Ltd. Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
US8410117B2 (en) * 2010-03-26 2013-04-02 Hoffmann-La Roche Inc. Imidazopyrimidine derivatives
RU2015147450A (ru) * 2013-04-29 2017-06-05 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ 2-ФЕНИЛ ИЛИ 2-ГЕТЕРОАРИЛ ИМИДАЗОЛ[1,2-a]ПИРИДИНА

Also Published As

Publication number Publication date
WO2014187762A1 (en) 2014-11-27
EP2999701A1 (en) 2016-03-30
SI2999701T1 (sl) 2017-08-31
JP2016520091A (ja) 2016-07-11
HK1213558A1 (zh) 2016-07-08
KR101770494B1 (ko) 2017-08-22
AR096371A1 (es) 2015-12-23
EP2999701B1 (en) 2017-04-12
ES2629389T3 (es) 2017-08-09
RU2665580C2 (ru) 2018-08-31
KR20150144796A (ko) 2015-12-28
RU2015149528A (ru) 2017-06-28
JP6130055B2 (ja) 2017-05-17
CN105229009B (zh) 2017-09-29
HUE033612T2 (en) 2017-12-28
BR112015025140A2 (pt) 2017-07-18
CN105229009A (zh) 2016-01-06
US20170128598A1 (en) 2017-05-11
DK2999701T3 (en) 2017-07-10
CA2907605A1 (en) 2014-11-27
AU2014270524A8 (en) 2015-09-24
AU2014270524A1 (en) 2015-09-17
US9801961B2 (en) 2017-10-31
AU2014270524B2 (en) 2018-01-04
ZA201506570B (en) 2017-02-22
TW201500360A (zh) 2015-01-01
SG11201509503QA (en) 2015-12-30
RU2015149528A3 (pl) 2018-03-22
MX2015015893A (es) 2016-03-04

Similar Documents

Publication Publication Date Title
ZA201506570B (en) 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
IL243092B (en) New triazolo[d–4,5]pyrimidine histories
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
IL246028B (en) Compounds 2 - amino - 6 - fluoro - n - [ - fluoro - pyridine - 3 yl] pyrazolo (1, 5 - a ) pyrimidine - 3 - carboxamide, their solid forms, preparations containing them and methods for their preparation
PT2794611T (pt) Pirazolo[1,5-a]pirimidinas como agentes antivirais
SI2963043T1 (sl) Derivat tetrahidroimidazo(1,5-d)(1,4)oksazepina
AP2015008867A0 (en) 3,4-dihydroisquinolin-2(1h)-yl compounds
EP3067356A4 (en) Pyrrolo pyrimidine derivative
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
HUE043108T2 (hu) (5,6-dihidro)pirimido[4,5-e]indolizinek
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
IL242162B (en) Pyrrolo [2, 3 –d] pyrimidine derivatives as 2cb receptor agonists
ZA201507389B (en) 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives
ZA201507151B (en) Antiviral indolo[2,3-b]quinoxaline
EP3227292A4 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
PT3330271T (pt) Composto de pirrolo[2,3-d]pirimidina ou sal do mesmo
HK1240222A1 (en) 4h-pyrido[1,2-a]pyrimidin-4-one compounds
GB201219129D0 (en) Triazolo(4,5-d)pyrmindine compounds
AU2014904868A0 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS